Search

everythinglearnresearchcommunity

for

Search:↓

Different levels of microRNAs in different parts of the scalp can cause male pattern baldness.

Certain genes and X chromosome patterns may significantly contribute to the development of hair loss.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Finasteride and dutasteride may lower melanoma risk, with teenage acne possibly indicating higher risk.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

Genetic defects in androgen production are linked to male developmental disorders and are improving treatment understanding.

Continued research and awareness are needed to improve treatments for androgen-dependent diseases.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

Researchers found a gene in hamsters that responds to male hormones and may be indirectly controlled by them.

Knowing how skin works and its diseases helps doctors diagnose and treat skin conditions better.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

Androgens slow hair growth by altering Wnt signaling in balding cells.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

The secretome from mesenchymal stromal cells shows promise for improving facial nerve injury treatment.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

Testosterone helps beard and axillary hair cells grow by releasing growth factors from dermal papilla cells.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Women of child-bearing age with androgenic alopecia lose hair density, especially in certain areas, and their hair becomes thinner. They also lose more than twice as much hair as healthy women.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Microparticles containing artocarpin extract could effectively treat hair loss and acne with minimal side effects.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Finasteride safely treats enlarged prostate and male-pattern baldness.

Hair loss gene linked to prostate issues.